Geographic Scope: Worldwide
Countries: Afghanistan, Bangladesh, Benin, Myanmar, Cambodia, Democratic Republic of Congo, Nepal
Client(s): International Vaccine Access Center (IVAC)
Services: Technical Assistance, Capacity Development
Technical Expertise: Universal Health Coverage, Immunization, Newborn and Child Health
Diarrhea is one of the world's leading killers of children, and rotavirus is the most common cause of severe diarrhea. Each year, rotavirus kills about 200,000 children and hospitalizes hundreds of thousands more, despite the availability of safe, effective rotavirus vaccines that can protect children from disease and death. Over 90 million infants worldwide lack access to the vaccine - sixty million of which live in Gavi, the Vaccine Alliance-focus countries that have not yet introduced the vaccine into their health systems.
The Rotavirus Accelerated Vaccine Introduction Network (RAVIN) is a partnership led by Johns Hopkins Bloomberg School of Public Health International Vaccine Access Center (IVAC), in collaboration with JSI and CDC, designed to provide technical support to countries considering introducing the vaccine into their national immunization programs. As IVAC leads advocacy efforts to accelerate the decision making process, JSI works closely with Ministries of Health and in-country partners in focus countries to support the successful introduction of the vaccine.
JSI's technical assistance includes supporting the development of quality introduction grant applications to Gavi, contributing to comprehensive introduction planning and roll-out of the vaccine in-country, and providing post-launch supportive supervision and monitoring. The RAVIN Project's focus countries include Afghanistan, Bangladesh, Benin, Cambodia, DR Congo, Myanmar and Nepal. In addition, the project will maximize opportunities at regional meetings and through its networks to support accelerated decision making and rotavirus introduction in other countries in the African and Asian regions.